The Association of Aplasia Cutis Congenita with Therapy of Maternal Thyroid Disease
- 1 September 1986
- journal article
- case report
- Published by Wiley in Pediatric Dermatology
- Vol. 3 (4) , 327-330
- https://doi.org/10.1111/j.1525-1470.1986.tb00534.x
Abstract
Aplasia cutis congenita, the localized absence of skin at birth, usually is an isolated scalp defect. We examined an infant with aplasia cutis congenita associated with maternal Grave's disease and the use of methimazole during pregnancy. This association was reported twice before. It has certain implications with respect to therapy of pregnant hyperthyroid women.Keywords
This publication has 18 references indexed in Scilit:
- Antithyroid DrugsNew England Journal of Medicine, 1984
- THYROTOXICOSIS IN PREGNANCY: RESULTS OF TREATMENT BY ANTITHYROID DRUGS COMBINED WITH T4Clinical Endocrinology, 1983
- Congenital absence of skinJournal of the American Academy of Dermatology, 1980
- Congenital skin defects and fetus papyraceusThe Journal of Pediatrics, 1977
- Hereditary Aplasia Cutis Congenita and Associated DefectsClinical Pediatrics, 1977
- Aplasia cutis congenita in three successive generationsArchives of Dermatology, 1973
- Aplasia cutis congenitaArchives of Dermatology, 1970
- Congenital defects of the scalpJournal of Neurosurgery, 1970
- Congenital Absence of the Scalp with Associated Vascular AnomalyClinical Pediatrics, 1965
- Congenital Defect of the Scalp: An Infant with a Bullous Lesion at BirthArchives of Disease in Childhood, 1948